Newstral
Vertex Pharmaceuticals Inc.
- Non-opioid proves effective for acute surgical & non-surgical painnewatlas.com
- FDA approves gene-editing treatment for sickle cell diseaseDallas News
- FDA to Review Vertex Pharmaceutical’s Application for CRISPR-based Gene Therapy Exa-celjdsupra.com
- Moderna's Revolutionary Cancer Vaccine Sets Investors AbuzzForbes
- PUniversity of Iowa professor wins prestigious award for his work on cystic fibrosispress-citizen.com
- ITop biotech stocks to watch in 2022invezz.com
- UThe next 10 years to revolve around organic expansion of Spinal Cord Trauma Treatment Market (CAGR of 3.7%) from 2017-2025unlvrebelyell.com
- Vertex, Incyte fall; Precigen, Magnachip riseSeattle Times
- Uber, UPS rise; Vertex Pharmaceuticals, BP falldailyherald.com
- Gene Editing Shows Promise in Sickle-Cell Diseasewsj.com
- Cystic fibrosis patients, doctors celebrate FDA's 'life-changing' approval of new treatmentFox News
- NFDA Approves Drug to Treat 90% of Cystic Fibrosis Patientsnbcsandiego.com
- Facing medicine shortages, Brits are eyeing ScotlandSan Jose Mercury News
- TCystic Fibrosis: Finding the Silver Liningtmn.truman.edu
- 2017’s top gainers may be in trouble next yeartriblive.com
- Analysis: AbbVie's HCV drug-price war threatens Gilead's dominancedailyherald.com
- Trump’s pick to lead FDA is confirmed by Senate - Tue, 09 May 2017 PSTThe Spokesman-Review
- Dave & Buster's declines while Sonic, Target jumpThe Salt Lake Tribune
Frequent names
Newstral's extraction of names of people and organisations from the world's news is completely automated. If you do not want your name to appear here, please contact us. We will be happy to look at your request.